NCT00226551View on ClinicalTrials.gov

Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 1999

Conditions
Coronary Disease
Interventions
DRUG

Isoproterenol

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT00226551 - Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms | Biotech Hunter | Biotech Hunter